Preview Mode Links will not work in preview mode

Jul 27, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr Matulonis on the following topics:

  • Perspective on the use of immune checkpoint inhibitor (ICI) therapy for patients with ovarian cancer (00:00)
  • Incorporation of pembrolizumab and pembrolizumab/lenvatinib into the management of endometrial cancer; optimal duration and schedule of pembrolizumab therapy (5:33)

CME information and select publications